Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection

European Journal of Neurology

Volumn 13, Issue 9, 2006, Pages 937-941

  Boukhris, S ^a   Magy, L ^a   Senga Mokono, U ^a   Loustaud Ratti, V ^a   Vallat, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Cryoglobulinemia; Demyelinating polyneuropathy; Hepatitis C virus; Peripheral neuropathy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN; INTERFERON; RIBAVIRIN; STEROID;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CEREBROSPINAL FLUID; CRYOGLOBULINEMIA; DEMYELINATION; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; LABORATORY TEST; MOTOR DYSFUNCTION; NERVE CONDUCTION; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SENSORY DYSFUNCTION; SURAL NERVE;

AGED; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DEMYELINATING DISEASES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; STEROIDS;

EID: 33747841969     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01416.x     Document Type: Article

References (18)

1. Mac Murray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Seminars in Arthritis and Rheumatism 1997; 26: 689-701.
2. Loustaud V, Lunel F. Extra-hepatic manifestations of HCV infection. Update in Hepatology 2002; 0: 28-45.
3. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biological and clinical significance of cryoglobulinemia. American Journal of Medicine 1974; 57: 775-788.
4. Cacoub P. Virus de l'hépatite C et atteintes neurologiques. Gastroenterologie clinique et biologique 1998; 22: 889-890.
5. Authier FJ, Bassez G, Payan C, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003; 60: 808-812.
6. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnosis features. Muscle and Nerve 1989; 12: 435-451.
7. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 291-300.
8. Adinolfi LE, Utili R, Attanasio V, et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: a prospective study. The Italian journal of gastroenterology 1996; 28: 169.
9. Ripault MP, Borderie C, Dumas P, et al. Neuropathies pé riphériques et hépatite chronique virale C: une association fréquente? Gastroenterologie Clinique et Biologique 1998; 22: 891-896.
10. Tembl JL, Ferre JM, Sevilla MT, Lago A, Mayordomo F, Vilchez J. Neurologic complications associated with hepatitis C virus infection. Neurology 1999; 53: 861-864.
11. Cacoub P, Wechsler B, Maisonobe T, Pariser P, Piette JC. Polyradiculonévrite inflammatoire démyélinisante chronique et virus de l'hépatite C. Revue de Medecine Interne 1999; 20: 1146-1151.
12. Endo K, Hoshi A, Shimizu M, et al. Marked thickening of the peripheral nerves in chronic inflammatory polyradiculoneuropathy associated with HCV infection. Rinsho Shinkeigaku. Clinical Neurology 2002; 42: 27-31.
13. Corcia P, Barbereau D, Guennoc AM, De Toffol B, Bacq Y. Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy. Neurology 2004; 63: 179-180.
14. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617-618.
15. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology 2001; 50: 195-201.
16. Nicolas G, Maisonobe T, Le Forestier N, Léger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle and Nerve 2002; 25: 26-30.
17. Vallat JM, Tabaraud F, Magy L, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle and Nerve 2003; 27: 478-485.
18. Zeuzem S, Heathcote JE, Martin N, Nieforth K, Modi M. Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy. Expert opinion on investigational drugs 2001; 10: 2201-2213.